Skip to main content
. 2019 Jun 17;21(9):1197–1209. doi: 10.1093/neuonc/noz095

Table 1.

Patient demographics and genetic information

Total Patients, n = 463 Age, mean ± SD, y
Sex
 Male 272 (58.7%) 52.7 ± 15.3
 Female 191 (41.3%) 51.6 ± 14.1
WHO grade and IDH
II Wildtype 17 (3.7%) 48.7 ± 16.3
Mutant 15 (3.2%) 44.3 ± 10.9
III Wildtype 60 (13.0%) 52.2 ± 15.2
Mutant 82 (17.7%) 40.9 ± 10.2
IV Wildtype 261 (56.4%) 57.5 ± 13.5
Mutant 28 (6.0%) 43.4 ± 13.9
WHO grade and 1p/19q
II Codeleted 7 (1.5%) 41.4 ± 10.8
Non-codeleted 25 (5.4%) 48.1 ± 14.6
III Codeleted 41 (8.9%) 42.2 ± 9.3
Non-codeleted 101 (21.8%) 47.1 ± 14.9
IV Codeleted 8 (1.7%) 54.6 ± 16.7
Non-codeleted 281 (60.7%) 56.1 ± 14.1